News

Daily Briefing: Temasek co-leads $142m funding in biotech firm; Jetstar Asia extends flight suspension to 31 May

And four in five Singaporeans tap into vacation memories to deal with work stress.

Daily Markets Briefing: STI up 1.92%

DBS led the gains amongst top active stocks with a 8.72% expansion.

Zalora rolls out environmental search filters

Customers can now search for eco-friendly products as demand shifts to sustainable commerce.

Majority of Singaporeans opt for contactless payments: survey

The coronavirus brought concerns about cash usage in the Lion City.

Accelerating Asia launches accelerator programme

Eligible startups will receive up to $200,000 investment via SAFE notes.

SIA's shareholders greenlights $15b fundraising

Shareholders in favour of raising two resolutions.

HDB launches Yishun Avenue 9 site for tender

The tender period will last for six months.

Renewables and gas-related solutions to lift Keppel's revenue: analyst

The O&M division’s operating profit remained strong at $28m, versus $3m in Q1 2019.

Grab urges staff to take voluntary no-pay leave

The firm might not be able to provide financial support for drivers after 1 June.

MPA to roll out $27m support package for maritime industry

MaritimeSG Together Package to take effect from 1 May.

IBF, WSG launch immersion programme

This would help professionals start a technology career in the financial sector.

FLCT's NPI climbed 14.2% to $50.47m in Q2

DPU edged up 4.4% YoY to 1.73 cents.

SPH REIT secures 5-year refinancing for $280m loan

Portfolio weighted average debt term to maturity expected to increase to three years.

Yangzijiang's net profit halved to $82.72m in Q1

Less number of vessels were delivered during the period.

Keppel's net profit flops 21% to $160m in Q1

Profit contraction attributed to 70% divestment of interest.

Raffles Medical's profits down 45.4% to $7.5m in Q1

Profits were dragged down by the pandemic’s impact on its China units. Raffles Medical Group’s profits for the first quarter of the decade fell 45.4% YoY to $7.5m from $13.5m in the previous year, dragged down by its China Healthcare Division that was “severely impacted” by the COVID-19 pandemic, the group revealed in a company update.